Catalytic charaelterization and cytokine mediated regulation of cytochrome P450 4Fs in rat hepatocytes

被引:24
|
作者
Kalsotra, Auinash [1 ]
Anakk, Sayeepriyadarshini
Brommer, Chad L.
Kikuta, Yasushi
Morgan, Edward T.
Strobel, Henry W.
机构
[1] Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77225 USA
[2] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA
[3] Fukuyama Univ, Dept Appl Biol Sci, Fukuyama, Hiroshima 7290292, Japan
关键词
cytochrome P4504F; eicosanoids; cytokines; STAT3; inflammation; interleukin-6; leukotriene B-4;
D O I
10.1016/j.abb.2007.02.027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochrome P450 (CYP) 4F mediated leukotriene B-4 (LTB4) metabolism modulates inflammation during injury and infection. Here we show that in addition to LTB4, the recombinant rat CYP4Fs catalyze omega-hydroxylations of lipoxin A(4), and hydroxyeicosatetraeonic acids. CYP4F gene regulation studies in primary hepatocytes reveal that pro-inflammatory cytokines interleukin (IL) -1 beta, IL-6 and tumor necrosis factor (TNF) -alpha produce a general inductive response whereas IL-10, an anti-inflammatory cytokine, suppresses CYP4F expression. The molecular mechanism behind IL-6 related induction of CYP4F4 and 4F5 is partially signal transducer and activator of transcription 3 (STAT3) dependent. When hepatocytes are subjected to high concentrations of LTB4 or prostaglandin E-2, lipid mediators of inflammation, only an increase in CYP4F5 mRNA expression is observed. Collectively, the results from isozyme activity and substrate driven CYP4F induction do not support the notion that an autoregulatory pathway could control the excessive concentrations of LTB4 during an inflammatory challenge to hepatocytes. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:104 / 112
页数:9
相关论文
共 50 条
  • [21] Prediction of cytochrome P450 mediated metabolism
    Olsen, Lars
    Oostenbrink, Chris
    Jorgensen, Flemming Steen
    ADVANCED DRUG DELIVERY REVIEWS, 2015, 86 : 61 - 71
  • [22] Cytochrome P450 Mediated Bioactivation of Saracatinib
    Chen, Jiaming
    Peng, Ying
    Zheng, Jiang
    CHEMICAL RESEARCH IN TOXICOLOGY, 2016, 29 (11) : 1835 - 1842
  • [23] Regulation of cytochrome p450 expression by β-catenin
    Braeuning, A.
    Koehle, C.
    Buchmann, A.
    Schwarz, M.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 72 - 72
  • [24] CYTOCHROME P450 GENE-REGULATION
    HANKINSON, O
    KEMPER, B
    DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1987, 6 (06): : 515 - 517
  • [25] DIETARY-REGULATION OF CYTOCHROME P450
    ANDERSON, KE
    KAPPAS, A
    ANNUAL REVIEW OF NUTRITION, 1991, 11 : 141 - 167
  • [26] Regulation of cytochrome P450 expression by sphingolipids
    Merrill, AH
    Nikolova-Karakashian, M
    Schmelz, EM
    Morgan, ET
    Stewart, J
    CHEMISTRY AND PHYSICS OF LIPIDS, 1999, 102 (1-2) : 131 - 139
  • [27] Physiological and pathophysiological regulation of cytochrome P450
    Morgan, ET
    Sewer, MB
    Iber, H
    Gonzalez, FJ
    Lee, YH
    Tukey, RH
    Okino, S
    Vu, T
    Chen, YH
    Sidhu, JS
    Omiecinski, CJ
    DRUG METABOLISM AND DISPOSITION, 1998, 26 (12) : 1232 - 1240
  • [28] Regulation of cytochrome P450 by posttranslational modification
    Aguiar, M
    Masse, R
    Gibbs, BF
    DRUG METABOLISM REVIEWS, 2005, 37 (02) : 379 - 404
  • [29] Cytochrome P450 3A and their regulation
    Burk, O
    Wojnowski, L
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 (01) : 105 - 124
  • [30] Cytochrome P450 3A and their regulation
    Oliver Burk
    Leszek Wojnowski
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2004, 369 : 105 - 124